Substituted 6-azabenzimidazole compounds
US11071730B2 · kind B2 · utility
4Cited by
5References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2019 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | Jan 29, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to certain 6-azabenzimidazole compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions disclosed herein may be used for the treatment or prevention of diseases, disorders, or infections modifiable by hematopoietic progenitor kinase 1 (HPK1) inhibitors, such as HBV, HIV, cancer, and/or a hyper-proliferative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.